AskVantage

Firefly Neuroscience

Firefly Neuroscience is a US startup, founded in 2022. It has raised at least $2.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2022Founded
StartupStage
United StatesHeadquarters
HealthcareIndustry
$2.2m+Raised (SEC filings)
SeedFunding stage
Healthcare
See it on the interactive mapBook a Briefing

Funding

Firefly Neuroscience has raised at least $2.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

Related

Questions and answers

What does Firefly Neuroscience do?

Firefly Neuroscience is classed in healthcare in its filings with the US Securities and Exchange Commission.

How much has Firefly Neuroscience raised?

At least $2.2m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Firefly Neuroscience based?

Firefly Neuroscience is registered in United States; its operating headquarters is not yet confirmed.

When was Firefly Neuroscience founded?

Firefly Neuroscience was founded in 2022.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.